These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 6232031

  • 1. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA, Nakata C, Nishitani H.
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract] [Full Text] [Related]

  • 2. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 3. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 4. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Nahorski SR.
    Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract] [Full Text] [Related]

  • 6. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G, Phan T, Uzan A.
    Life Sci; 1980 Apr 07; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract] [Full Text] [Related]

  • 7. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 07; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 8. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE.
    J Neurosci Res; 1984 Apr 07; 12(4):571-81. PubMed ID: 6512888
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
    Seeman P, Grigoriadis D.
    Biochem Pharmacol; 1985 Nov 15; 34(22):4065-6. PubMed ID: 4062976
    [No Abstract] [Full Text] [Related]

  • 10. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K, Sato M, Otsuki S.
    Biol Psychiatry; 1982 Feb 15; 17(2):223-31. PubMed ID: 7200378
    [Abstract] [Full Text] [Related]

  • 11. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT, Matsokis NA, Valcana T.
    J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223
    [Abstract] [Full Text] [Related]

  • 12. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL, Cross AJ, Longden A, Owen F, Poulter M.
    Eur J Pharmacol; 1979 Oct 01; 58(3):341-2. PubMed ID: 510367
    [No Abstract] [Full Text] [Related]

  • 13. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 14. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T, Manzo L, Costa LG.
    Immunopharmacology; 1991 Jul 09; 22(2):93-105. PubMed ID: 1662188
    [Abstract] [Full Text] [Related]

  • 15. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May 09; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 16. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ, Waddington JL, Ross ST.
    Life Sci; 1983 Jun 13; 32(24):2733-40. PubMed ID: 6222234
    [Abstract] [Full Text] [Related]

  • 17. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes.
    Agnati LF, Fuxe K, Battistini N, Benfenati F.
    Acta Physiol Scand; 1984 Mar 13; 120(3):465-7. PubMed ID: 6331074
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K, Meller E, Goldstein M, Benfenati F, Agnati LF.
    Neurosci Lett; 1986 Feb 28; 64(2):163-8. PubMed ID: 3960398
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR, Nahorski SR.
    Life Sci; 1980 Feb 18; 26(7):511-7. PubMed ID: 7366332
    [No Abstract] [Full Text] [Related]

  • 20. Detection of multiple receptors for dopamine.
    Spano PF, Memo M, Stefanini E, Fresia P, Trabucchi M.
    Adv Biochem Psychopharmacol; 1980 Feb 18; 21():243-51. PubMed ID: 7376971
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.